Have your own idea? Try our Stock Screener
Last week, the Biotech industry hasn't moved much but 3SBio is up 20% in that time. The past year has been better, since the industry has gained 22% in that time. As for the next few years, earnings are expected to grow by 44% per annum.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 14 Mar 2025 | HK$448.4b | HK$52.6b | -HK$16,843,493,146.19 | 21.7x | -26.6x | 8.5x |
Sun, 09 Feb 2025 | HK$377.0b | HK$52.0b | -HK$17,298,881,792.01 | 13.7x | -21.8x | 7.2x |
Tue, 07 Jan 2025 | HK$367.7b | HK$51.7b | -HK$17,179,422,330.91 | 11.8x | -21.4x | 7.1x |
Thu, 05 Dec 2024 | HK$399.2b | HK$52.1b | -HK$17,333,018,180.47 | 11.1x | -23x | 7.7x |
Sat, 02 Nov 2024 | HK$390.8b | HK$52.9b | -HK$17,787,896,875.13 | 11.3x | -22x | 7.4x |
Mon, 30 Sep 2024 | HK$384.6b | HK$53.0b | -HK$18,425,316,174.16 | 11.9x | -20.9x | 7.3x |
Wed, 28 Aug 2024 | HK$337.3b | HK$53.7b | -HK$18,758,882,140.47 | 11.2x | -18x | 6.3x |
Fri, 26 Jul 2024 | HK$312.5b | HK$49.8b | -HK$19,533,248,939.31 | 11.8x | -16x | 6.3x |
Sun, 23 Jun 2024 | HK$332.5b | HK$49.7b | -HK$19,449,051,702.56 | 11.4x | -17.1x | 6.7x |
Tue, 21 May 2024 | HK$371.0b | HK$49.8b | -HK$19,367,659,887.46 | 12.2x | -19.2x | 7.5x |
Thu, 18 Apr 2024 | HK$324.1b | HK$49.6b | -HK$19,910,867,416.24 | 10.7x | -16.3x | 6.5x |
Sat, 16 Mar 2024 | HK$366.5b | HK$47.2b | -HK$20,336,879,317.71 | 17.6x | -18x | 7.8x |
Mon, 12 Feb 2024 | HK$321.6b | HK$47.0b | -HK$20,274,962,687.09 | 15.5x | -15.9x | 6.8x |
Wed, 10 Jan 2024 | HK$378.5b | HK$47.1b | -HK$20,324,950,537.00 | 17.6x | -18.6x | 8x |
Fri, 08 Dec 2023 | HK$403.9b | HK$47.0b | -HK$20,301,292,526.00 | 17.5x | -19.9x | 8.6x |
Sun, 05 Nov 2023 | HK$413.3b | HK$45.2b | -HK$18,919,413,159.00 | 12.9x | -21.8x | 9.2x |
Tue, 03 Oct 2023 | HK$400.6b | HK$45.0b | -HK$19,140,443,270.00 | 13.9x | -20.9x | 8.9x |
Thu, 31 Aug 2023 | HK$392.2b | HK$43.4b | -HK$16,560,885,846.00 | 15.1x | -23.7x | 9x |
Sat, 29 Jul 2023 | HK$427.6b | HK$35.5b | -HK$23,368,379,129.00 | 28x | -18.3x | 12x |
Mon, 26 Jun 2023 | HK$386.4b | HK$35.6b | -HK$23,401,635,975.00 | 24.1x | -16.5x | 10.9x |
Wed, 24 May 2023 | HK$436.6b | HK$36.1b | -HK$23,815,835,639.00 | 30.1x | -18.3x | 12.1x |
Fri, 21 Apr 2023 | HK$443.5b | HK$37.0b | -HK$24,172,668,230.00 | 18.6x | -18.3x | 12x |
Sun, 19 Mar 2023 | HK$405.8b | HK$32.4b | -HK$35,522,328,250.00 | 22.9x | -11.4x | 12.5x |
Tue, 14 Feb 2023 | HK$445.5b | HK$34.8b | -HK$35,139,835,760.00 | 31.5x | -12.7x | 12.8x |
Thu, 12 Jan 2023 | HK$441.8b | HK$34.9b | -HK$35,233,612,905.00 | 29.6x | -12.5x | 12.7x |
Sat, 10 Dec 2022 | HK$392.8b | HK$33.6b | -HK$33,903,437,875.00 | 24.6x | -11.6x | 11.7x |
Mon, 07 Nov 2022 | HK$356.4b | HK$33.8b | -HK$32,491,041,863.00 | 18.5x | -11x | 10.6x |
Wed, 05 Oct 2022 | HK$286.6b | HK$34.0b | -HK$32,534,935,782.00 | 17.3x | -8.8x | 8.4x |
Fri, 02 Sep 2022 | HK$335.0b | HK$34.2b | -HK$33,506,026,858.00 | 15.7x | -10x | 9.8x |
Sun, 31 Jul 2022 | HK$328.6b | HK$32.9b | -HK$46,359,653,984.00 | 13x | -7.1x | 10x |
Tue, 28 Jun 2022 | HK$381.5b | HK$33.1b | -HK$46,719,776,226.00 | 14.7x | -8.2x | 11.5x |
Thu, 26 May 2022 | HK$321.4b | HK$34.3b | -HK$46,256,256,982.00 | 12.8x | -6.9x | 9.4x |
Sat, 23 Apr 2022 | HK$332.4b | HK$36.0b | -HK$45,702,949,061.00 | 12.9x | -7.3x | 9.2x |
Mon, 21 Mar 2022 | HK$324.3b | HK$34.8b | -HK$33,336,593,534.00 | 13.2x | -9.7x | 9.3x |
-9.7x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 1.05% | |
Healthcare | 0.55% | |
Biotech | -0.45% | |
Biotech | -0.45% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1530 3SBio | HK$9.03 | 20.4% +HK$3.6b | 70.1% | PE12x | |
2142 HBM Holdings | HK$8.30 | 23.9% +HK$1.2b | 435.5% | PE36.5x | |
2315 Biocytogen Pharmaceuticals (Beijing) | HK$13.60 | 24.5% +HK$1.1b | 29.5% | PS6.3x | |
2509 Qyuns Therapeutics | HK$10.56 | 47.7% +HK$757.3m | n/a | PS36.6x | |
1672 Ascletis Pharma | HK$7.56 | 6.5% +HK$442.6m | 361.0% | PS672.2x |